Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Abbott's Infinity DBS is the first FDA approved directional Deep Brain Stimulation (DBS) system to allow targeting of a specific area of the brain that is critical to motor functions
Approximately 60,000 Americans are diagnosed with Parkinson's disease... Devices, Neurology, FDA Abbott, Infinity, Deep Brain Stimulation, Parkinson's Disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news